跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
查看斯高帕斯 (Scopus) 概要
駱 俊良
教授
生物醫學工程學系
https://orcid.org/0000-0002-5026-3584
電話
02-2826-7914(office) , 02-2826-7000#65569, 65517, 65531(lab)
電子郵件
cllo
nycu.edu
tw
網站
https://menadionekimo.wixsite.com/mysite-1
h-index
h10-index
h5-index
2220
引文
27
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
698
引文
18
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
342
引文
9
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
1999 …
2026
每年研究成果
概覽
指紋
網路
研究成果
(54)
類似的個人檔案
(5)
指紋
查看啟用 Chun-Liang Lo 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Micelle
97%
Copolymer
83%
Doxorubicin
72%
Nanoparticle
56%
Neoplasm
56%
Polyethylene Glycol
30%
Chemotherapy Regimens
26%
Drug Release
25%
Cytotoxicity
25%
Anticarcinogen
23%
Liposome
22%
Reactive Oxygen Metabolite
22%
Colon Carcinoma
20%
Immunotherapy
16%
Hypoxia
16%
Breast Cancer
16%
Small Interfering RNA
16%
Macrogol
14%
Micellar System
13%
Tumor Microenvironment
13%
Nanomaterial
12%
Lipid
12%
Alpha Tocopherol
12%
Glutathione
11%
Macrogol Derivative
11%
Cancer Chemotherapy
11%
Imiquimod
10%
Methacrylate
9%
Histidine
8%
Nanomedicine
8%
Triple Negative Breast Cancer
8%
Ceramide
7%
Combination Therapy
7%
Pyridoxal
7%
Hydrophile
7%
Focal Adhesion Kinase
6%
Janus Kinase 1
6%
Intracellular Drug Delivery
6%
Folic Acid
6%
Acrylamide
6%
Photothermal Therapy
6%
Transcytosis
6%
Oral Administration
6%
Glucosamine
6%
Camptothecin
6%
Tumor Growth
6%
Hyaluronic Acid
6%
Poly(methacrylic Acid)
5%
Side Effect
5%
Keyphrases
Diblock Copolymer
46%
Doxorubicin
42%
Cancer Cells
35%
Mixed Micelles
27%
Doxorubicin-loaded
25%
Graft Copolymer
23%
PH-sensitive
22%
Drug Delivery
22%
Tumor
20%
In Cancer
19%
Cancer Treatment
19%
Cancer Stem Cells
17%
Anticancer Drugs
17%
Copolymer
16%
Cancer Therapy
16%
Vitamin E
16%
Polymer Nanoparticles
16%
Poly(D,L-lactide)
15%
Nanoparticles
14%
Liposomes
14%
Polymeric Micelles
14%
Tumor Accumulation
14%
Liposomal
13%
PEG-PLA
13%
Intracellular Drug Delivery
12%
Therapeutic Efficacy
11%
Nanotherapeutics
10%
Multifunctional Polymer
10%
Lipophilic Complex
10%
Co-delivery
10%
Doxorubicin Delivery
10%
Reactive Oxygen Species-responsive
10%
Methoxy Poly(ethylene glycol)
10%
Doxorubicin Drug
10%
Tumor Extracellular Matrix
10%
Biocompatibility
10%
Polymeric Nanoparticles
9%
Cytotoxicity
9%
Particle Size
9%
Matrix pH
9%
PH-induced
9%
Endosome
9%
Cellular Uptake
8%
Targeted Cancer Therapy
8%
Nanomedicine
8%
Extracellular Matrix
8%
Photothermal Therapy
8%
Triple-negative Breast Cancer
8%
Photothermal
8%
Combination Therapy
7%